Dr. Jun Moni Kalita


Dr. Jun Moni Kalita

Associate Professor & HoD


Dr. Jun Moni Kalita, an Associate Professor of Pharmaceutical Chemistry at the School of Pharmaceutical Sciences, Girijananda Chowdhury University, has made significant strides in the field of pharmaceutical research and education.

Dr. Kalita embarked on his academic journey with a thirst for knowledge and a deep passion for pharmaceutical chemistry. He holds a Master of Pharmacy (M. Pharm) degree with a specialization in pharmaceutical chemistry, a testament to his early commitment to understanding the intricacies of pharmaceutical compounds. Building on this foundation, he went on to earn his Doctor of Philosophy (Ph.D.) in pharmaceutical sciences, solidifying his expertise and paving the way for his future contributions.

With over 11 years of invaluable experience in both teaching and research, Dr. Kalita has become a revered figure in the academic community. As an Associate Professor, he has dedicated his career to imparting knowledge and inspiring the next generation of pharmaceutical scientists. His commitment to education is unwavering, and his students benefit from his vast knowledge and dedication to their success.

Dr. Kalita is engaged in research for the last 11 years. His work primarily revolves around the dynamic fields of computer-aided drug design and synthetic chemistry. By leveraging advanced computational techniques and innovative approaches, he aims to expedite the discovery and development of pharmaceutical compounds. His contributions in these areas have not only expanded the boundaries of pharmaceutical science but have also offered new solutions to critical healthcare challenges.

Beyond his academic and research pursuits, Dr. Kalita possesses a rich and diverse set of interests. He is an avid sports enthusiast, finding solace and enjoyment in various physical activities. Whether it’s on the field, court, or track, his passion for sports adds balance to his life and reflects his dedication to a healthy and active lifestyle.

Dr. Kalita also has wanderlust for exploring the world. Traveling is not just a hobby for him; it’s a way to broaden his horizons, experience diverse cultures, and gain new perspectives. His adventures in different corners of the globe have not only enriched his personal life but also provided inspiration for his work in pharmaceutical chemistry.


  • Bachelor of Pharmacy 2009University of North Bengal
  • Master's of Pharmacy in Pharmaceutical Chemistry 2012Dibrugarh University
  • Ph.D in Pharmaceutical Science 2018 Dibrugarh University


  • Das A, Ghosh S.K. , Bhat H.R., Kalita J.M., Kashyap A., Adhikari N. Docking,(2019). Current Bioactive Compounds. DOI: 10.2174/1573407215666190308154139. (IF: 0.69)2. Sahu S, Ghosh S.K, Kalita J.M., Ginjupalli M.C., Kranthi R.K. Discovery of potential1,3,5-triazine compounds against strains of plasmodium falciparum using supervisedmachine learning models (2019). Eu. J. of Pharm. Sc.https://doi.org/10.1016/j.ejps.2019.105208. (IF: 3.532)
  • Das S., Dash S., Laloo D., Dasgupta D., Kalita J.M. Anticancer Activity of Active Constituents Isolated from n-Butanolic Extracts of Flacourtia jangomas (Salicaceae) (2018). Asian J. Org. Med. Chem., 3(3), 89-94
  • Kalita J.M., Ghosh S.K., Sahu S., Dutta M. Ratinal design and microwave assisted synthesis of some novel phenyl thiazolyl clubbed s-triazine derivatives as antimalarial antifolate (2017). Future journal of pharmaceutical sciences. 3(1), 11-17
  • Gahtori P., Pandey R., Kumar V., Ghosh S.K., Das A., Kalita J.M., Sahu S., Prakash A., Bhattacharyya D. R. Towards resistance-compromised DHFR inhibitors: part 1. Combined structure/ligand-based virtual screening and ADME-Tox proiling (2016). Journal of Chemometrics, 30 (8), 462-481. (IF: 1.84)
  • Das A., Gogoi U, Kalita J.M, Sandilya S. Molecular Docking Study of a Series of Substituted Xanthone Derivatives as Novel COX-2 Inhibitors Targeting Prostaglandin Endoperoxide Synthase -2. Current Enzyme Inhibition (2016), 12(2), 195-204.
  • Sahu S., Ghosh S. K., Kalita J. M., Dutta M., Bhat H. R. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf DHFR-TS (2016). Experimental Parasitology, 163, 38-45. (IF: 1.85)
  • Sahu S., Ghosh S. K., Ghoshal A., Kalita J.M., Gahtori P., Bhattacharyya D. R. Microwave assisted synthesis, antimalarial screening and structure–activityrelationship exploration of some phenylthiazolyl-triazine derivatives against dihydrofolate reductase (2016). Medicinal Chemistry Research, 25(12), 2916-2923. (IF: 1.72)
  • Kalita J. M., Ghosh S. K., Sahu S., Dutta M., Bhat H. R. Docking and crystal structure analysis of some phenyl thiazolyl triazine derivatives with quadrapole mutant pfdhfrts enzyme and their synthesis (2015). World Journal of Pharmacy and Pharmaceutical Sciences, 4(2), 1040- 1049.
  • Kalita J.M., Ghosh S.K., Sahu S., Dutta M. A statistical analysis to find out an appropriate docking method (2015). Asian Joural of Pharmaceutical and Clinical Research, 8(1), 158-160

Award, Fellowship & Recognition

  • GATE-2009, University topper for B. Pharm (2009) University of North Bengal, GPAT-2010, University topper for M. Pharm (2012) Dibrugarh University.